10.1007/s10495-013-0873-z 55 LazarovT.Juarez-CarreoS.CoxN.GeissmannF
At Cymbiotika, we approach wellness differently
Mitochondria dysfunction in CD8+ T cells as an important contributing factor for cancer development and a potential target for cancer treatment: a review
For personal use (buying research peptides for yourself) Risk level: Very low Reality: No documented cases of individuals prosecuted for possessing research peptides for personal use FDA focuses on companies selling, not individual users No federal law criminalizing personal possession of most research peptides (exception: HGH) Worst case scenarios: Customs seizure if importing (lose money, no criminal charges typically) Theoretical future regulation change (unlikely to be retroactive) For selling peptides Risk level: High Reality: FDA actively pursues companies making medical claims Selling as "human medicine" without approval is illegal Companies face warning letters, seizures, potential criminal charges Recent enforcement examples: Companies shut down for marketing unapproved peptides Warning letters issued frequently Criminal charges rare but possible for egregious cases For medical practitioners Risk level: Moderate Reality: Prescribing off-label through compounding pharmacies: Generally safe Operating peptide clinic properly: Legal Making false medical claims: Risk of medical board action Practicing medicine without license: Criminal For athletes Risk level: High (career consequences) Reality: Not criminal prosecution Career-ending bans possible Loss of medals, titles, sponsorships WADA testing increasingly sophisticated Learn about testing concerns in our peptides for athletic performance guide
A 2021 New England Journal of Medicine trial showed participants on semaglutide lost an average of 15.3 kg compared to 2.6 kg in the placebo group over 68 weeks
Pharmacological Reports, 73(6), 10201032
